Skip to content
Search

Latest Stories

3 in 10 eligible women do not take up NHS cervical screening invitations

3 in 10 eligible women do not take up NHS cervical screening invitations

Less number of women attended screening in 2022-23, compared to the previous year

NHS England has urged women to accept cervical screening invites to make it possible to eliminate the disease within the next two decades.


Screening using a highly effective test helps detect human papillomavirus (HPV), which is responsible for over 99 per cent of all cervical cancers.

Sadly, three in ten of those eligible for screening do not take up the potentially life-saving offer, as shown by the NHS Cervical Screening Programme, England 2022-2023 annual report.

The report, published by NHSE on Thursday, showed that a total of 4.62 million women aged 25 to 64 for cervical screening was invited to book an appointment in 2022-23, and 3.43 million attended the screening.

Less number of women attended screening in 2022-23 (68.7 per cent), compared to the previous year (69.9 per cent).

The proportion was higher for 50- to 64-year-olds at 74.4 per cent, compared to 65.8 per cent per cent for 25- to 49-year-olds.

Steve Russell, Chief Delivery Officer and National Director for Vaccinations and Screening for NHS England, said that elimination of cervical cancer in 2040 is possible, but it relies on “millions of people continuing to come forward for screening and vaccinations every year.”

Dr Kiren Collison, a GP and NHS England’s Deputy Medical Director for Primary Care reminded women that getting the HPV vaccination and attending screening is “the best way of preventing cervical cancer”, and so they must book an appointment when invited.

If you have previously received an invitation but couldn’t attend at the time, you don’t have to wait to get another invitation.

“You can still book a cervical screening appointment even if you were invited weeks, months or years ago,” said Dr Kiren.

Last week the NHS pledged to eliminate cervical cancer by 2040 by making HPV vaccination easily accessible to people and increasing cervical screening uptake.

Women are invited for screening every three to five years depending on their age, or more frequently if HPV is detected.

Those who have been vaccinated against HPV should also attend cervical screening appointments as “the vaccine does not provide protection from all types of HPV,” the NHS noted.

The NHS cervical screening programme saves thousands of lives every year, noted Nicola Smith, Senior Health Information Manager at Cancer Research UK, as he encouraged “women and people with a cervix, such as trans men and non-binary people assigned female at birth” to take part.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less